Overview Dividends

(RXO) RXO - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74982T1034

Truckload, Brokerage, Managed, Freight, Forwarding

Cargo Ground Transportation
Market Cap in USD: 1,882m
IPO / Inception: 2022-10-27
Return 12m vs S&P 500: -57.4%

Dividends

Currently no dividends paid
Risk via 10d forecast
Volatility 86.1%
Value at Risk 5%th 131%
Relative Tail Risk -7.85%
Reward TTM
Sharpe Ratio -0.77
Alpha -77.55
CAGR/Max DD -0.11
Character TTM
Hurst Exponent 0.609
Beta 1.967
Beta Downside 1.991
Drawdowns 3y
Max DD 67.15%
Mean DD 22.07%
Median DD 15.09%

Description: RXO RXO November 09, 2025

RXO, Inc. (NYSE:RXO) operates as a truck-brokerage firm across North America, Asia, and Europe, offering asset-light truckload brokerage, managed transportation, last-mile delivery, and freight-forwarding services that include ocean and air logistics, customs brokerage, and domestic support. The company was incorporated in 2022 following its spin-off from XPO Logistics and is headquartered in Charlotte, North Carolina.

Key operational metrics indicate a growing market presence: FY 2023 revenue reached roughly $2.0 billion, with an adjusted EBITDA margin of about 7 %, and the firm reported handling over 15 million truckload shipments. RXO’s performance is closely tied to macro-drivers such as sustained e-commerce growth, persistent driver shortages that tighten capacity, and volatile fuel prices that affect brokerage spreads. The asset-light model positions the company to scale quickly without heavy capital expenditures, a strategic advantage in a sector where capital intensity can constrain profitability.

For a deeper quantitative dive into RXO’s valuation metrics and peer comparison, the ValueRay platform offers a concise, data-rich overview worth checking out.

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (-79.0m TTM) > 0 and > 6% of Revenue (6% = 356.4m TTM)
FCFTA -0.01 (>2.0%) and ΔFCFTA 0.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 4.95% (prev 7.98%; Δ -3.03pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.01 (>3.0%) and CFO 37.0m > Net Income -79.0m (YES >=105%, WARN >=100%)
Net Debt (657.0m) to EBITDA (124.0m) ratio: 5.30 <= 3.0 (WARN <= 3.5)
Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (168.6m) change vs 12m ago 25.72% (target <= -2.0% for YES)
Gross Margin 16.53% (prev 17.77%; Δ -1.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 180.2% (prev 113.8%; Δ 66.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.09 (EBITDA TTM 124.0m / Interest Expense TTM 34.0m) >= 6 (WARN >= 3)

Altman Z'' 0.04

(A) 0.09 = (Total Current Assets 1.20b - Total Current Liabilities 907.0m) / Total Assets 3.20b
(B) -0.11 = Retained Earnings (Balance) -338.0m / Total Assets 3.20b
(C) 0.00 = EBIT TTM 3.00m / Avg Total Assets 3.30b
(D) -0.21 = Book Value of Equity -348.0m / Total Liabilities 1.62b
Total Rating: 0.04 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 33.41

1. Piotroski 2.50pt
2. FCF Yield -0.71%
3. FCF Margin -0.30%
4. Debt/Equity 0.43
5. Debt/Ebitda 5.30
6. ROIC - WACC (= -9.92)%
7. RoE -4.96%
8. Rev. Trend 22.24%
9. EPS Trend -39.50%

What is the price of RXO shares?

As of December 05, 2025, the stock is trading at USD 14.24 with a total of 1,688,431 shares traded.
Over the past week, the price has changed by +7.72%, over one month by -18.07%, over three months by -12.96% and over the past year by -51.42%.

Is RXO a buy, sell or hold?

RXO has received a consensus analysts rating of 3.10. Therefor, it is recommend to hold RXO.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 14
  • Sell: 1
  • Strong Sell: 2

What are the forecasts/targets for the RXO price?

Issuer Target Up/Down from current
Wallstreet Target Price 15.6 9.5%
Analysts Target Price 15.6 9.5%
ValueRay Target Price 13.2 -7.2%

RXO Fundamental Data Overview November 25, 2025

Market Cap USD = 1.88b (1.88b USD * 1.0 USD.USD)
P/E Forward = 96.1538
P/S = 0.3169
P/B = 1.1914
P/EG = 6.4258
Beta = 1.539
Revenue TTM = 5.94b USD
EBIT TTM = 3.00m USD
EBITDA TTM = 124.0m USD
Long Term Debt = 387.0m USD (from longTermDebt, last quarter)
Short Term Debt = 93.0m USD (from shortTermDebt, last quarter)
Debt = 682.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 657.0m USD (from netDebt column, last quarter)
Enterprise Value = 2.54b USD (1.88b + Debt 682.0m - CCE 25.0m)
Interest Coverage Ratio = 0.09 (Ebit TTM 3.00m / Interest Expense TTM 34.0m)
FCF Yield = -0.71% (FCF TTM -18.0m / Enterprise Value 2.54b)
FCF Margin = -0.30% (FCF TTM -18.0m / Revenue TTM 5.94b)
Net Margin = -1.33% (Net Income TTM -79.0m / Revenue TTM 5.94b)
Gross Margin = 16.53% ((Revenue TTM 5.94b - Cost of Revenue TTM 4.96b) / Revenue TTM)
Gross Margin QoQ = 16.61% (prev 17.90%)
Tobins Q-Ratio = 0.79 (Enterprise Value 2.54b / Total Assets 3.20b)
Interest Expense / Debt = 1.32% (Interest Expense 9.00m / Debt 682.0m)
Taxrate = 6.67% (-1.00m / -15.0m)
NOPAT = 2.80m (EBIT 3.00m * (1 - 6.67%))
Current Ratio = 1.32 (Total Current Assets 1.20b / Total Current Liabilities 907.0m)
Debt / Equity = 0.43 (Debt 682.0m / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 5.30 (Net Debt 657.0m / EBITDA 124.0m)
Debt / FCF = -36.50 (negative FCF - burning cash) (Net Debt 657.0m / FCF TTM -18.0m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.47% (Net Income -79.0m / Total Assets 3.20b)
RoE = -4.96% (Net Income TTM -79.0m / Total Stockholder Equity 1.59b)
RoCE = 0.15% (EBIT 3.00m / Capital Employed (Equity 1.59b + L.T.Debt 387.0m))
RoIC = 0.14% (NOPAT 2.80m / Invested Capital 1.99b)
WACC = 10.06% (E(1.88b)/V(2.56b) * Re(13.26%) + D(682.0m)/V(2.56b) * Rd(1.32%) * (1-Tc(0.07)))
Discount Rate = 13.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.74%
Fair Price DCF = unknown (Cash Flow -18.0m)
EPS Correlation: -39.50 | EPS CAGR: -66.51% | SUE: -0.05 | # QB: 0
Revenue Correlation: 22.24 | Revenue CAGR: 1.84% | SUE: -0.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=-0.057 | Revisions Net=+0 | Analysts=14
EPS next Year (2026-12-31): EPS=0.20 | Chg30d=-0.160 | Revisions Net=-8 | Growth EPS=+2058.9% | Growth Revenue=+3.5%

Additional Sources for RXO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle